Non-Paraneoplastic Autoimmune Retinopathy

Non-Paraneoplastic Autoimmune Retinopathy

Oporto JI, Mori A, Oporto J. Non-paraneoplastic Autoimmune Retinopathy. J Ophthalmol Sci. 2020;2(1):1-5 Review Article Open Access Non-paraneoplastic Autoimmune Retinopathy Joaquín I. Oporto1*, Antonia Mori1, Jorge Oporto2 1Facultad de Medicina, Pontificia Universidad Católica de Chile, Santiago, Chile 2Fundación Oftalmológica Los Andes, La Serena, Chile Article Info Abstract Article Notes Non-paraneoplastic autoimmune retinopathy (npAIR) is a rare non- Received: March 02, 2020 inflammatory immune mediated disease caused by circulating autoantibodies Accepted: April 09, 2020 against the retina. Its mechanisms are still not fully understood. It is characterized *Correspondence: by bilateral, often symmetric, rapidly progressive visual loss, visual field defects Mr. Joaquín I. Oporto. Facultad de Medicina, Pontificia and photoreceptor dysfunction. Fundoscopy is usually unaltered in the early Universidad Católica de Chile, Santiago, Chile; Email: stages, and full field electroretinogram (ERG), visual field, optical coherence [email protected]; ORCID ID: http://orcid.org/0000-0001-7877-3626. tomography (OCT), fundus autofluorescence (FAF) and fluorescein angiography may help with the diagnosis. Determination of circulating antibodies is crucial, ©2020 Oporto JI. This article is distributed under the terms of the Creative Commons Attribution 4.0 International License. as well as ruling-out any possible malignancy with a full physical examination and complimentary exams. Early and aggressive treatment is crucial to prevent Keywords: further retinal damage. More studies are needed in order to determine more Autoimmune retinopathy accurate diagnostic criteria, better management and follow-up that could AIR preserve visual function and even improve it. Non-paraneoplastic Anti-recoverin Anti-α-enolase Rituximab Introduction Sarilumab Immunosuppression ERG OCT autoantibodiesAutoimmune against retinopathies the retina (AIR)1 are a group of non-inflammatory retinopathies caused by crossed reactivity or specific circulating2. The exact mechanisms are still not fully understood, and it still remains an under diagnosed disease AIR is usually divided into two categories: (1) paraneoplastic AIR, which can be further subdivided into cancer associated retinopathy (CAR) and melanoma associated retinopathy (MAR); and (2) non- paraneoplastic AIR (npAIR). npAIR is the most common type of AIR and there is a predominance of3,4 females, especially with previous history of autoimmune diseases . CAR is more. frequently associated to small-cell lung cancer, breast cancer and other4,5 gynecologic cancers such as uterine, ovarian and cervical cancers The disease is characterized by rapidly progressive, often symmetric and painless visual loss, visual field defects and photoreceptor dysfunction. Clinical examination is usually unremarkable in the early stages, although some patients6–8. may present with retinal pigment epithelium (RPE) anomalies, vascular attenuation, optic disk pallor and diffuse retinal atrophy The exact prevalence and risk factors are unknown. The. The disease most is more3,9,10 common in females during the fifth or sixth6,11 decade of life , although there are reports of younger. patients common finding in fundus autofluorescence10 (FAF) is the presence of hyperfluorescent spots around the macula diagnosisThe objective and initiate is to reviewappropriate the current treatment. standards of npAIR and get a better understanding of the disease in order to achieve a prompt Page 1 of 5 Oporto JI, Mori A, Oporto J. Non-paraneoplastic Autoimmune Retinopathy. J Ophthalmol Sci. 2020;2(1):1-5 Journal of Ophthalmological Science Pathophysiology 7 9 . photoaversion , and prolonged dark adaptation . Although7,11,25,26 the disease is bilateral, asymmetry is not uncommon There are several types of retinal proteins that may be antigenic. Initially, the most commonly associated proteins Examination is commonly7 unaltered, but signs of vascular attenuation, diffuse retinal atrophy,11 changes in the were recoverin, which is a 23-kDa calcium-binding protein7. found in photoreceptors, and α-enolase, which is a 48-kDa RPE, optic disk pallor , RPE atrophy, mottling and6 granular glycolytic enzyme found in retinal and non-retinal tissues pigment changes at the fovea can appear . Pigment spiculas Later studies have demonstrated12 that the presence of anti- can also be seen after long-term follow-up . This last recoverin autoantibodies is infrequent,13 and only detected offinding the disease. may resemble other entities and ultimately result in 5% of patients with CAR . Over 30 different antigens in misdiagnosis of npAIR and explain the underdiagnosis have been associated with vision loss , such as tubby-like protein (65-kDa), HSC 70 (80-kDa), Carbonic anhydrase Although there is a lack of diagnostic criteria, a II (30-kDa), transducing β (35-kDa), photoreceptor-cell- consensus established some conditions that are useful for specific nuclear receptor (44.7-kDa), Müller-cell-specific the diagnosis: (1) no evidence of other causes that may be antigen (35-kDa), transient receptor potential cation responsible for visual abnormalities such as malignancies, channel subfamily M member 1 (TRPM1, 182-kDa), inflammation, infection, drugs, trauma, hereditary targetsarrestin1 (48-kDa), interphotoreceptor retinoid-binding conditions or others; (2) ERG anomalies; (3) presence of protein (IRBP, 141-kDa) and other unidentified antigen serum antibodies; (4) absence of other27. lesions or retinal . Some of them have higher incidence than anti- degeneration that may explain the visual loss; and (5) recoverin autoantibodies. absence of overt ocular inflammation It is thought that the disease is triggered by molecular Other diagnoses that should be ruled out are acute mimicry between tumor antigens and the previously zonal occult outer retinopathy (AZOOR), hereditary cone described retinal proteins, but this theory is not able dystrophies, idiopathic big blind spot syndrome, retinal to explain the trigger for npAIR, which may be related degenerative disorders such as retinitis pigmentosa1,11 and to infectious (viral or bacterial) proteins. Studies have posterior uveitis,1. and vitamin A deficiency . AZOOR and demonstrated that retinal injury can be mediated by other uveitic syndromes can be ruled out with characteristic cytotoxic T14 cells and autoantibodies to detect self-antigens FAF findings 28–33. in the cell . These autoantibodies can penetrate13. the cells Table 1 summarizes the main clinical and exam findings and affect cellular function by inducing caspase 3 pathway ofComplimentary npAIR and other Examsdifferential diagnoses apoptosis and other metabolic pathways The presence of autoantibodies is helpful, but 7 not sufficient in the diagnosis of AIR, as they can be Initial absence of clinical findings makes the diagnosis found in other retinal and systemic diseases such as challenging and imaging support is needed . Although retinitis pigmentosa, Vogt-Koyanagi-Harada disease, there are no specific signs and reports regarding full Behcet’s disease, sympathetic ophthalmia, toxoplasma field electroretinogram (ERG) findings in npAIR are heterogenous, alterations in both cone and rod responses chorioretinitis, macular degeneration,1,15–19 diabetic retinopathy, vasculitis and idiopathic uveitis , as well as serum of are possible manifestations of the disease.1 Abnormalities . in dark-adapted or light-adapted responses, and bipolar healthy individuals20–23 or patients with cancer but no signs of cell response have also been described . Visual field loss ocularClinical disease Features is variable and progressive, but most reports describe constriction of the visual9,11 field with or without central or . The presence of more paracentral scotomas . FAF shows hyperfluorescent Clinical presentation greatly depends24 on the type of areas around the macula and fluorescein angiography may affected cells and antibodies involved support the diagnosis by ruling out other entities with than one antibody produces a symptom overlap that may characteristic findings. result in diagnostic delays. Cone dysfunction is associated to photoaversion, hemeralopia, dyschromatopsia and Optical coherence tomography (OCT) is useful to diminished visual acuity, and rod impairment is5 associated provide information, including the presence of cystoid8. to nyctalopia and peripheral visual field loss . Although macular edema (CME) and loss of outer retinal layers CAR is usually associated to cone dysfunction, and MAR is whichsegments may include disruption of the ellipsoid zone (EZ) associated to rod impairment, npAIR could compromise Areas around9 the macula can show8. loss of inner and outer both types of cells, resulting in a more complex phenotype. The presence of CME is associated to decreased ERG amplitudes and faster EZ loss Patients typically present with rapidly progressive visual loss, scotomas, dyschromatopsia, nyctalopia, Several laboratory techniques are useful in determining Page 2 of 5 Oporto JI, Mori A, Oporto J. Non-paraneoplastic Autoimmune Retinopathy. J Ophthalmol Sci. 2020;2(1):1-5 Journal of Ophthalmological Science Table 1: Differential diagnosis Fundus autofluores- Optical coherence Clinical features Fundus features Visual field Electrophysiology cence (FAF) and fluores- tomography cein angiography (FFA) Outer retinal Rapid, painless and abnormalities, in- progressive visual Initially unal- cluding loss of pho- loss. Often bilater- tered with later toreceptor layer, Hyperfluorescent para-

View Full Text

Details

  • File Type
    pdf
  • Upload Time
    -
  • Content Languages
    English
  • Upload User
    Anonymous/Not logged-in
  • File Pages
    5 Page
  • File Size
    -

Download

Channel Download Status
Express Download Enable

Copyright

We respect the copyrights and intellectual property rights of all users. All uploaded documents are either original works of the uploader or authorized works of the rightful owners.

  • Not to be reproduced or distributed without explicit permission.
  • Not used for commercial purposes outside of approved use cases.
  • Not used to infringe on the rights of the original creators.
  • If you believe any content infringes your copyright, please contact us immediately.

Support

For help with questions, suggestions, or problems, please contact us